Mononucleosis Diagnostic Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, End User, and Geography

PUBLISHED: November 27, 2024

PAGES: 210 Pages

DELIVERY TIME: 1-5 business days

ADD TO COMPARE

SELECT AN OPTION

According to our new research study on "Mononucleosis Diagnostic Market Forecast to 2031 -Global Analysis - by Type, End User, and Geography," the market is anticipated to grow from US$ 151.44 million in 2023 and is projected to reach US$ 222.15 million by 2031; it is expected to register a CAGR of 4.9% during 2023-2031. High risk among the adolescent population, and the rising health awareness and knowledge about mononucleosis are contributing to the growing mononucleosis diagnostic market size. However, the low accuracy of existing diagnostic tests hampers the mononucleosis diagnostic market growth. Further, advancements in molecular diagnostics in mononucleosis diagnostic are expected to bring in new mononucleosis diagnostic market trends in the coming years.

In terms of revenue, North America dominated the mononucleosis diagnostic market in 2023. It is estimated to dominate the global market during the forecast period. The US is the largest market for mononucleosis diagnostics in the world, and it is estimated to dominate the market during the forecast period as well. The mononucleosis diagnostic market growth in the US is attributed to technological advancements, increased awareness, and a constant need for effective disease management strategies. According to the National Institutes of Health, the US records ~125,000 cases of infectious mononucleosis every year. Owing to such a high number, the awareness of the mononucleosis caused by the Epstein-Barr virus (EBV) is also on the rise in the country, which bolsters the demand for rapid and accurate diagnostic test kits, consumables, and services. Various testing methods adopted by healthcare providers in the country include serological tests based on antibody detection and molecular tests focused on viral DNA identification. The competitive landscape of the mononucleosis diagnostics market in the US is dominated by companies such as Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers. These companies invest in innovation and collaborations to enhance their product offerings and expand their market presence.

Mononucleosis Diagnostic Market Analysis

Development of Point-of-Care Testing to Provide Market Opportunities in Future

POC testing allows for rapid diagnosis at or near the site of patient care, enabling healthcare providers to make immediate clinical decisions and improve patient outcomes. Traditional laboratory tests often require hours or days to generate results, which can delay treatment and worsen symptoms. In contrast, POC tests can deliver results within minutes, facilitating timely intervention. The rapid turnaround is especially crucial for conditions such as mononucleosis, as early diagnosis can reduce complications and enhance patient comfort. POC testing can be implemented in various healthcare settings, including outpatient clinics, emergency departments, and home care settings. The accessibility is particularly beneficial in areas with limited laboratory infrastructure or in rural regions with insufficient healthcare resources. Bringing diagnostic capabilities closer to patients in the form of POC testing ensures that more individuals receive timely diagnoses and appropriate care, thereby broadening the reach of healthcare services. Moreover, this type of testing promotes greater engagement, as patients can receive their results quickly and discuss the next steps with their healthcare providers.

POC testing can be more cost-effective compared to traditional laboratory testing as they don't need extensive laboratory infrastructure, in turn lowering the overall costs for healthcare systems. The affordability of mononucleosis testing further drives its accessibility to a broader range of patients, especially in underserved populations. Recent advancements in biosensors and microfluidic technologies are driving the development of more sophisticated POC tests with improved sensitivity and specificity. These innovations ensure the reliability of POC tests in detecting mononucleosis. Mononucleosis diagnostic market players offering POC test kits include SEKISUI Diagnostics (OSOM Mono Test), Abbott (Clearview Mono), and Cardinal Health [Cardinal Health MONO (Mononucleosis) II Rapid Test]. Thus, the development of POC testing generates substantial growth opportunities for the mononucleosis diagnostics market players.

Mononucleosis Diagnostic Market Report Segmentation Analysis

Key segments that contributed to the derivation of the mononucleosis diagnostic market analysis are type and end user.

Based on type, the mononucleosis diagnostic market is segmented into Epstein Barr Virus antibody test, complete blood count test, and monospot test. The monospot test segment held the largest mononucleosis diagnostic market share of the market in 2023.

In terms of end user, the mononucleosis diagnostic market is categorized into hospitals, laboratories, and others. The hospitals segment dominated the market in 2023.

Mononucleosis Diagnostic Market: Competitive Landscape and Key Developments

Abbott Laboratories, Arlington Scientific Inc, Bio-Rad Laboratories Inc, Cardinal Health Inc, Meridian Bioscience Inc, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc, QuidelOrtho Corp, F. Hoffmann-La Roche Ltd, QIAGEN NV, Hologic Inc, bioMerieux SA, DiaSorin SpA, Immunostics Inc., Launch Diagnostics Ltd, Biorex Diagnostics, and ZEUS Scientific are among the key companies operating in the mononucleosis diagnostic market.

The United Nations Children's Fund (UNICEF), National Library of Medicine, Centers for Disease Control and Prevention (CDC), National Institutes of Health, Statistics Canada, Federal Statistical Office (Destatis) are among the primary and secondary sources referred to while preparing the mononucleosis diagnostic market report.

Product Code: TIPRE00019689

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Mononucleosis Diagnostics Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Mononucleosis Diagnostics Market - Key Market Dynamics

5.1 Mononucleosis Diagnostics Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 High Risk among Adolescent Population
- 5.2.2 Rising Health Awareness and Knowledge About Mononucleosis
5.3 Market Restraints
- 5.3.1 Low Accuracy of Existing Diagnostic Tests
5.4 Market Opportunities
- 5.4.1 Development of Point-of-Care Testing
5.5 Future Trends
- 5.5.1 Advancements in Molecular Diagnostics
5.6 Impact of Drivers and Restraints:

6. Mononucleosis Diagnostics Market - Global Market Analysis

6.1 Mononucleosis Diagnostics Market Revenue (US$ Thousand), 2021-2031
6.2 Mononucleosis Diagnostics Market Forecast Analysis

7. Mononucleosis Diagnostics Market Analysis - by Type

7.1 Monospot Test
- 7.1.1 Overview
- 7.1.2 Monospot Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
7.2 Epstein Barr Virus Antibody Test
- 7.2.1 Overview
- 7.2.2 Epstein Barr Virus Antibody Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
7.3 Complete Blood Count Test
- 7.3.1 Overview
- 7.3.2 Complete Blood Count Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)

8. Mononucleosis Diagnostics Market Analysis - by End User

8.1 Hospital
- 8.1.1 Overview
- 8.1.2 Hospital: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
8.2 Laboratories
- 8.2.1 Overview
- 8.2.2 Laboratories: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)

9. Mononucleosis Diagnostics Market - Geographical Analysis

9.1 North America
- 9.1.1 North America Mononucleosis Diagnostics Market Overview
- 9.1.2 North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
- 9.1.3 North America: Mononucleosis Diagnostics Market Breakdown, by Type
  - 9.1.3.1 North America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
- 9.1.4 North America: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.1.4.1 North America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
- 9.1.5 North America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.1.5.1 United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.1.5.1.1 United States: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.1.5.1.2 United States: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.1.5.2 Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.1.5.2.1 Canada: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.1.5.2.2 Canada: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.1.5.3 Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.1.5.3.1 Mexico: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.1.5.3.2 Mexico: Mononucleosis Diagnostics Market Breakdown, by End User
9.2 Europe
- 9.2.1 Europe Mononucleosis Diagnostics Market Overview
- 9.2.2 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  - 9.2.2.1 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
  - 9.2.2.2 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
- 9.2.3 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.2.3.1 Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.2.3.1.1 Germany: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.2.3.1.2 Germany: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.2.3.2 United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.2.3.2.1 United Kingdom: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.2.3.2.2 United Kingdom: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.2.3.3 France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.2.3.3.1 France: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.2.3.3.2 France: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.2.3.4 Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.2.3.4.1 Italy: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.2.3.4.2 Italy: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.2.3.5 Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.2.3.5.1 Spain: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.2.3.5.2 Spain: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.2.3.6 Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.2.3.6.1 Rest of Europe: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.2.3.6.2 Rest of Europe: Mononucleosis Diagnostics Market Breakdown, by End User
9.3 Asia Pacific
- 9.3.1 Asia Pacific Mononucleosis Diagnostics Market Overview
- 9.3.2 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  - 9.3.2.1 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
  - 9.3.2.2 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
- 9.3.3 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.3.3.1 China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.3.3.1.1 China: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.3.3.1.2 China: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.3.3.2 Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.3.3.2.1 Japan: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.3.3.2.2 Japan: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.3.3.3 India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.3.3.3.1 India: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.3.3.3.2 India: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.3.3.4 Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.3.3.4.1 Australia: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.3.3.4.2 Australia: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.3.3.5 South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.3.3.5.1 South Korea: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.3.3.5.2 South Korea: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.3.3.6 Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.3.3.6.1 Rest of APAC: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.3.3.6.2 Rest of APAC: Mononucleosis Diagnostics Market Breakdown, by End User
9.4 South and Central America
- 9.4.1 South and Central America Mononucleosis Diagnostics Market Overview
- 9.4.2 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  - 9.4.2.1 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
  - 9.4.2.2 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
- 9.4.3 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.4.3.1 Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.4.3.1.1 Brazil: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.4.3.1.2 Brazil: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.4.3.2 Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.4.3.2.1 Argentina: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.4.3.2.2 Argentina: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.4.3.3 Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.4.3.3.1 Rest of South and Central America: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.4.3.3.2 Rest of South and Central America: Mononucleosis Diagnostics Market Breakdown, by End User
9.5 Middle East and Africa
- 9.5.1 Middle East and Africa Mononucleosis Diagnostics Market Overview
- 9.5.2 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  - 9.5.2.1 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
  - 9.5.2.2 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
- 9.5.3 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.5.3.1 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
  - 9.5.3.2 Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.5.3.2.1 Saudi Arabia: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.5.3.2.2 Saudi Arabia: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.5.3.3 South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.5.3.3.1 South Africa: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.5.3.3.2 South Africa: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.5.3.4 United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.5.3.4.1 United Arab Emirates: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.5.3.4.2 United Arab Emirates: Mononucleosis Diagnostics Market Breakdown, by End User
  - 9.5.3.5 Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 9.5.3.5.1 Rest of Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by Type
    - 9.5.3.5.2 Rest of Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by End User

10. Industry Landscape

10.1 Overview
10.2 Growth Strategies in Mononucleosis Diagnostic Market
10.3 Organic Growth Strategies
- 10.3.1 Overview
10.4 Inorganic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Abbott Laboratories
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Arlington Scientific Inc
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Bio-Rad Laboratories Inc
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Cardinal Health Inc
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Meridian Bioscience Inc
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Sekisui Diagnostics LLC
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Thermo Fisher Scientific Inc
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 QuidelOrtho Corp
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 F. Hoffmann-La Roche Ltd
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 QIAGEN NV
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
11.11 Hologic Inc
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Products and Services
- 11.11.4 Financial Overview
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments
11.12 bioMerieux SA
- 11.12.1 Key Facts
- 11.12.2 Business Description
- 11.12.3 Products and Services
- 11.12.4 Financial Overview
- 11.12.5 SWOT Analysis
- 11.12.6 Key Developments
11.13 DiaSorin SpA
- 11.13.1 Key Facts
- 11.13.2 Business Description
- 11.13.3 Products and Services
- 11.13.4 Financial Overview
- 11.13.5 SWOT Analysis
- 11.13.6 Key Developments
11.14 Immunostics Inc.
- 11.14.1 Key Facts
- 11.14.2 Business Description
- 11.14.3 Products and Services
- 11.14.4 Financial Overview
- 11.14.5 SWOT Analysis
- 11.14.6 Key Developments
11.15 Launch Diagnostics Ltd
- 11.15.1 Key Facts
- 11.15.2 Business Description
- 11.15.3 Products and Services
- 11.15.4 Financial Overview
- 11.15.5 SWOT Analysis
- 11.15.6 Key Developments
11.16 Biorex Diagnostics
- 11.16.1 Key Facts
- 11.16.2 Business Description
- 11.16.3 Products and Services
- 11.16.4 Financial Overview
- 11.16.5 SWOT Analysis
- 11.16.6 Key Developments
11.17 ZEUS Scientific
- 11.17.1 Key Facts
- 11.17.2 Business Description
- 11.17.3 Products and Services
- 11.17.4 Financial Overview
- 11.17.5 SWOT Analysis
- 11.17.6 Key Developments

12. Appendix

12.1 About the Insight Partners
12.2 Glossary of Terms for Mononucleosis Diagnostics Market

Product Code: TIPRE00019689

List Of Tables

Table 1. Mononucleosis Diagnostics Market Segmentation
Table 2. North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 3. North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 4. United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 5. United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 6. Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 7. Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 8. Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 9. Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 10. Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 11. Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 12. Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 13. Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 14. United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 15. United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 16. France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 17. France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 18. Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 19. Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 20. Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 21. Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 22. Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 23. Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 24. Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 25. Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 26. China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 27. China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 28. Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 29. Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 30. India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 31. India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 32. Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 33. Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 34. South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 35. South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 36. Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 37. Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 38. South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 39. South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 40. Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 41. Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 42. Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 43. Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 44. Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 45. Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 46. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 47. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 48. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Country
Table 49. Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 50. Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 51. South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 52. South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 53. United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 54. United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 55. Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
Table 56. Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
Table 57. Recent Organic Growth Strategies in Mononucleosis Diagnostic Market
Table 58. Recent Inorganic Growth Strategies in the Mononucleosis Diagnostic Market
Table 59. Glossary of Terms

List Of Figures

Figure 1. Mononucleosis Diagnostics Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Mononucleosis Diagnostics Market Revenue (US$ Thousand), 2021-2031
Figure 5. Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 6. Mononucleosis Diagnostics Market Share (%) - by Type (2023 and 2031)
Figure 7. Monospot Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 8. Epstein Barr Virus Antibody Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 9. Complete Blood Count Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 10. Mononucleosis Diagnostics Market Share (%) - by End User (2023 and 2031)
Figure 11. Hospital: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 12. Laboratories: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 13. Others: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
Figure 14. North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 15. North America: Mononucleosis Diagnostics Market Breakdown, by Type (2023 and 2031)
Figure 16. North America: Mononucleosis Diagnostics Market Breakdown, by End User (2023 and 2031)
Figure 17. North America: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 18. United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 19. Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 20. Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 21. Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 22. Europe: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 23. Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 24. United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 25. France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 26. Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 27. Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 28. Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 29. Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 30. Asia Pacific: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 31. China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 32. Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 33. India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 34. Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 35. South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 36. Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 37. South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 38. South and Central America: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 39. Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 40. Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 41. Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 42. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 43. Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 44. Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 45. South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 46. United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 47. Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
Figure 48. Growth Strategies in Mononucleosis Diagnostic Market